Chronic hepatitis B in adults w/ compensated liver disease w/ evidence of active viral replication, persistent elevated serum ALT levels & active liver inflammation &/or fibrosis. (Initiation of lamivudine treatment should only be considered when the use of an alternative antiviral agent w/ a higher genetic barrier is not available or appropriate.) Chronic hepatitis B in adult w/ decompensated liver disease in combination w/ a 2nd agent w/o cross-resistance to lamivudine.
J05AF05 - lamivudine ; Belongs to the class of nucleoside and nucleotide reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
Sign Out
